ICD-10-CM/PCS MS-DRG v41.1 Definitions Manual
Previous Page [Alt-p] Up a level [Alt-u] Next Page [Alt-n]
MDC 21 Injuries, poisonings and toxic effects of drugs
Assignment of Diagnosis Codes
Page 10 of 16
D47Z1 S21432A S51849A S66009S S76899A S96809A T3371XA T38991A T428X3A T45614A T493X4A T535X1S T608X1S T6391XS T782XXA T83728S
T45614APoisoning by thrombolytic drug, undetermined, initial encounter
T45614SPoisoning by thrombolytic drug, undetermined, sequela
T45615AAdverse effect of thrombolytic drugs, initial encounter
T45615SAdverse effect of thrombolytic drugs, sequela
T45621APoisoning by hemostatic drug, accidental (unintentional), initial encounter
T45621SPoisoning by hemostatic drug, accidental (unintentional), sequela
T45622APoisoning by hemostatic drug, intentional self-harm, initial encounter
T45622SPoisoning by hemostatic drug, intentional self-harm, sequela
T45623APoisoning by hemostatic drug, assault, initial encounter
T45623SPoisoning by hemostatic drug, assault, sequela
T45624APoisoning by hemostatic drug, undetermined, initial encounter
T45624SPoisoning by hemostatic drug, undetermined, sequela
T45625AAdverse effect of hemostatic drug, initial encounter
T45625SAdverse effect of hemostatic drug, sequela
T45691APoisoning by other fibrinolysis-affecting drugs, accidental (unintentional), initial encounter
T45691SPoisoning by other fibrinolysis-affecting drugs, accidental (unintentional), sequela
T45692APoisoning by other fibrinolysis-affecting drugs, intentional self-harm, initial encounter
T45692SPoisoning by other fibrinolysis-affecting drugs, intentional self-harm, sequela
T45693APoisoning by other fibrinolysis-affecting drugs, assault, initial encounter
T45693SPoisoning by other fibrinolysis-affecting drugs, assault, sequela
T45694APoisoning by other fibrinolysis-affecting drugs, undetermined, initial encounter
T45694SPoisoning by other fibrinolysis-affecting drugs, undetermined, sequela
T45695AAdverse effect of other fibrinolysis-affecting drugs, initial encounter
T45695SAdverse effect of other fibrinolysis-affecting drugs, sequela
T457X1APoisoning by anticoagulant antagonists, vitamin K and other coagulants, accidental (unintentional), initial encounter
T457X1SPoisoning by anticoagulant antagonists, vitamin K and other coagulants, accidental (unintentional), sequela
T457X2APoisoning by anticoagulant antagonists, vitamin K and other coagulants, intentional self-harm, initial encounter
T457X2SPoisoning by anticoagulant antagonists, vitamin K and other coagulants, intentional self-harm, sequela
T457X3APoisoning by anticoagulant antagonists, vitamin K and other coagulants, assault, initial encounter
T457X3SPoisoning by anticoagulant antagonists, vitamin K and other coagulants, assault, sequela
T457X4APoisoning by anticoagulant antagonists, vitamin K and other coagulants, undetermined, initial encounter
T457X4SPoisoning by anticoagulant antagonists, vitamin K and other coagulants, undetermined, sequela
T457X5AAdverse effect of anticoagulant antagonists, vitamin K and other coagulants, initial encounter
T457X5SAdverse effect of anticoagulant antagonists, vitamin K and other coagulants, sequela
T458X1APoisoning by other primarily systemic and hematological agents, accidental (unintentional), initial encounter
T458X1SPoisoning by other primarily systemic and hematological agents, accidental (unintentional), sequela
T458X2APoisoning by other primarily systemic and hematological agents, intentional self-harm, initial encounter
T458X2SPoisoning by other primarily systemic and hematological agents, intentional self-harm, sequela
T458X3APoisoning by other primarily systemic and hematological agents, assault, initial encounter
T458X3SPoisoning by other primarily systemic and hematological agents, assault, sequela
T458X4APoisoning by other primarily systemic and hematological agents, undetermined, initial encounter
T458X4SPoisoning by other primarily systemic and hematological agents, undetermined, sequela
T458X5AAdverse effect of other primarily systemic and hematological agents, initial encounter
T458X5SAdverse effect of other primarily systemic and hematological agents, sequela
T4591XAPoisoning by unspecified primarily systemic and hematological agent, accidental (unintentional), initial encounter
T4591XSPoisoning by unspecified primarily systemic and hematological agent, accidental (unintentional), sequela
T4592XAPoisoning by unspecified primarily systemic and hematological agent, intentional self-harm, initial encounter
T4592XSPoisoning by unspecified primarily systemic and hematological agent, intentional self-harm, sequela
T4593XAPoisoning by unspecified primarily systemic and hematological agent, assault, initial encounter
T4593XSPoisoning by unspecified primarily systemic and hematological agent, assault, sequela
T4594XAPoisoning by unspecified primarily systemic and hematological agent, undetermined, initial encounter
T4594XSPoisoning by unspecified primarily systemic and hematological agent, undetermined, sequela
T4595XAAdverse effect of unspecified primarily systemic and hematological agent, initial encounter
T4595XSAdverse effect of unspecified primarily systemic and hematological agent, sequela
T460X1APoisoning by cardiac-stimulant glycosides and drugs of similar action, accidental (unintentional), initial encounter
T460X1SPoisoning by cardiac-stimulant glycosides and drugs of similar action, accidental (unintentional), sequela
T460X2APoisoning by cardiac-stimulant glycosides and drugs of similar action, intentional self-harm, initial encounter
T460X2SPoisoning by cardiac-stimulant glycosides and drugs of similar action, intentional self-harm, sequela
T460X3APoisoning by cardiac-stimulant glycosides and drugs of similar action, assault, initial encounter
T460X3SPoisoning by cardiac-stimulant glycosides and drugs of similar action, assault, sequela
T460X4APoisoning by cardiac-stimulant glycosides and drugs of similar action, undetermined, initial encounter
T460X4SPoisoning by cardiac-stimulant glycosides and drugs of similar action, undetermined, sequela
T460X5AAdverse effect of cardiac-stimulant glycosides and drugs of similar action, initial encounter
T460X5SAdverse effect of cardiac-stimulant glycosides and drugs of similar action, sequela
T461X1APoisoning by calcium-channel blockers, accidental (unintentional), initial encounter
T461X1SPoisoning by calcium-channel blockers, accidental (unintentional), sequela
T461X2APoisoning by calcium-channel blockers, intentional self-harm, initial encounter
T461X2SPoisoning by calcium-channel blockers, intentional self-harm, sequela
T461X3APoisoning by calcium-channel blockers, assault, initial encounter
T461X3SPoisoning by calcium-channel blockers, assault, sequela
T461X4APoisoning by calcium-channel blockers, undetermined, initial encounter
T461X4SPoisoning by calcium-channel blockers, undetermined, sequela
T461X5AAdverse effect of calcium-channel blockers, initial encounter
T461X5SAdverse effect of calcium-channel blockers, sequela
T462X1APoisoning by other antidysrhythmic drugs, accidental (unintentional), initial encounter
T462X1SPoisoning by other antidysrhythmic drugs, accidental (unintentional), sequela
T462X2APoisoning by other antidysrhythmic drugs, intentional self-harm, initial encounter
T462X2SPoisoning by other antidysrhythmic drugs, intentional self-harm, sequela
T462X3APoisoning by other antidysrhythmic drugs, assault, initial encounter
T462X3SPoisoning by other antidysrhythmic drugs, assault, sequela
T462X4APoisoning by other antidysrhythmic drugs, undetermined, initial encounter
T462X4SPoisoning by other antidysrhythmic drugs, undetermined, sequela
T462X5AAdverse effect of other antidysrhythmic drugs, initial encounter
T462X5SAdverse effect of other antidysrhythmic drugs, sequela
T463X1APoisoning by coronary vasodilators, accidental (unintentional), initial encounter
T463X1SPoisoning by coronary vasodilators, accidental (unintentional), sequela
T463X2APoisoning by coronary vasodilators, intentional self-harm, initial encounter
T463X2SPoisoning by coronary vasodilators, intentional self-harm, sequela
T463X3APoisoning by coronary vasodilators, assault, initial encounter
T463X3SPoisoning by coronary vasodilators, assault, sequela
T463X4APoisoning by coronary vasodilators, undetermined, initial encounter
T463X4SPoisoning by coronary vasodilators, undetermined, sequela
T463X5AAdverse effect of coronary vasodilators, initial encounter
T463X5SAdverse effect of coronary vasodilators, sequela
T464X1APoisoning by angiotensin-converting-enzyme inhibitors, accidental (unintentional), initial encounter
T464X1SPoisoning by angiotensin-converting-enzyme inhibitors, accidental (unintentional), sequela
T464X2APoisoning by angiotensin-converting-enzyme inhibitors, intentional self-harm, initial encounter
T464X2SPoisoning by angiotensin-converting-enzyme inhibitors, intentional self-harm, sequela
T464X3APoisoning by angiotensin-converting-enzyme inhibitors, assault, initial encounter
T464X3SPoisoning by angiotensin-converting-enzyme inhibitors, assault, sequela
T464X4APoisoning by angiotensin-converting-enzyme inhibitors, undetermined, initial encounter
T464X4SPoisoning by angiotensin-converting-enzyme inhibitors, undetermined, sequela
T464X5AAdverse effect of angiotensin-converting-enzyme inhibitors, initial encounter
T464X5SAdverse effect of angiotensin-converting-enzyme inhibitors, sequela
T465X1APoisoning by other antihypertensive drugs, accidental (unintentional), initial encounter
T465X1SPoisoning by other antihypertensive drugs, accidental (unintentional), sequela
T465X2APoisoning by other antihypertensive drugs, intentional self-harm, initial encounter
T465X2SPoisoning by other antihypertensive drugs, intentional self-harm, sequela
T465X3APoisoning by other antihypertensive drugs, assault, initial encounter
T465X3SPoisoning by other antihypertensive drugs, assault, sequela
T465X4APoisoning by other antihypertensive drugs, undetermined, initial encounter
T465X4SPoisoning by other antihypertensive drugs, undetermined, sequela
T465X5AAdverse effect of other antihypertensive drugs, initial encounter
T465X5SAdverse effect of other antihypertensive drugs, sequela
T466X1APoisoning by antihyperlipidemic and antiarteriosclerotic drugs, accidental (unintentional), initial encounter
T466X1SPoisoning by antihyperlipidemic and antiarteriosclerotic drugs, accidental (unintentional), sequela
T466X2APoisoning by antihyperlipidemic and antiarteriosclerotic drugs, intentional self-harm, initial encounter
T466X2SPoisoning by antihyperlipidemic and antiarteriosclerotic drugs, intentional self-harm, sequela
T466X3APoisoning by antihyperlipidemic and antiarteriosclerotic drugs, assault, initial encounter
T466X3SPoisoning by antihyperlipidemic and antiarteriosclerotic drugs, assault, sequela
T466X4APoisoning by antihyperlipidemic and antiarteriosclerotic drugs, undetermined, initial encounter
T466X4SPoisoning by antihyperlipidemic and antiarteriosclerotic drugs, undetermined, sequela
T466X5AAdverse effect of antihyperlipidemic and antiarteriosclerotic drugs, initial encounter
T466X5SAdverse effect of antihyperlipidemic and antiarteriosclerotic drugs, sequela
T467X1APoisoning by peripheral vasodilators, accidental (unintentional), initial encounter
T467X1SPoisoning by peripheral vasodilators, accidental (unintentional), sequela
T467X2APoisoning by peripheral vasodilators, intentional self-harm, initial encounter
T467X2SPoisoning by peripheral vasodilators, intentional self-harm, sequela
T467X3APoisoning by peripheral vasodilators, assault, initial encounter
T467X3SPoisoning by peripheral vasodilators, assault, sequela
T467X4APoisoning by peripheral vasodilators, undetermined, initial encounter
T467X4SPoisoning by peripheral vasodilators, undetermined, sequela
T467X5AAdverse effect of peripheral vasodilators, initial encounter
T467X5SAdverse effect of peripheral vasodilators, sequela
T468X1APoisoning by antivaricose drugs, including sclerosing agents, accidental (unintentional), initial encounter
T468X1SPoisoning by antivaricose drugs, including sclerosing agents, accidental (unintentional), sequela
T468X2APoisoning by antivaricose drugs, including sclerosing agents, intentional self-harm, initial encounter
T468X2SPoisoning by antivaricose drugs, including sclerosing agents, intentional self-harm, sequela
T468X3APoisoning by antivaricose drugs, including sclerosing agents, assault, initial encounter
T468X3SPoisoning by antivaricose drugs, including sclerosing agents, assault, sequela
T468X4APoisoning by antivaricose drugs, including sclerosing agents, undetermined, initial encounter
T468X4SPoisoning by antivaricose drugs, including sclerosing agents, undetermined, sequela
T468X5AAdverse effect of antivaricose drugs, including sclerosing agents, initial encounter
T468X5SAdverse effect of antivaricose drugs, including sclerosing agents, sequela
T46901APoisoning by unspecified agents primarily affecting the cardiovascular system, accidental (unintentional), initial encounter
T46901SPoisoning by unspecified agents primarily affecting the cardiovascular system, accidental (unintentional), sequela
T46902APoisoning by unspecified agents primarily affecting the cardiovascular system, intentional self-harm, initial encounter
T46902SPoisoning by unspecified agents primarily affecting the cardiovascular system, intentional self-harm, sequela
T46903APoisoning by unspecified agents primarily affecting the cardiovascular system, assault, initial encounter
T46903SPoisoning by unspecified agents primarily affecting the cardiovascular system, assault, sequela
T46904APoisoning by unspecified agents primarily affecting the cardiovascular system, undetermined, initial encounter
T46904SPoisoning by unspecified agents primarily affecting the cardiovascular system, undetermined, sequela
T46905AAdverse effect of unspecified agents primarily affecting the cardiovascular system, initial encounter
T46905SAdverse effect of unspecified agents primarily affecting the cardiovascular system, sequela
T46991APoisoning by other agents primarily affecting the cardiovascular system, accidental (unintentional), initial encounter
T46991SPoisoning by other agents primarily affecting the cardiovascular system, accidental (unintentional), sequela
T46992APoisoning by other agents primarily affecting the cardiovascular system, intentional self-harm, initial encounter
T46992SPoisoning by other agents primarily affecting the cardiovascular system, intentional self-harm, sequela
T46993APoisoning by other agents primarily affecting the cardiovascular system, assault, initial encounter
T46993SPoisoning by other agents primarily affecting the cardiovascular system, assault, sequela
T46994APoisoning by other agents primarily affecting the cardiovascular system, undetermined, initial encounter
T46994SPoisoning by other agents primarily affecting the cardiovascular system, undetermined, sequela
T46995AAdverse effect of other agents primarily affecting the cardiovascular system, initial encounter
T46995SAdverse effect of other agents primarily affecting the cardiovascular system, sequela
T470X1APoisoning by histamine H2-receptor blockers, accidental (unintentional), initial encounter
T470X1SPoisoning by histamine H2-receptor blockers, accidental (unintentional), sequela
T470X2APoisoning by histamine H2-receptor blockers, intentional self-harm, initial encounter
T470X2SPoisoning by histamine H2-receptor blockers, intentional self-harm, sequela
T470X3APoisoning by histamine H2-receptor blockers, assault, initial encounter
T470X3SPoisoning by histamine H2-receptor blockers, assault, sequela
T470X4APoisoning by histamine H2-receptor blockers, undetermined, initial encounter
T470X4SPoisoning by histamine H2-receptor blockers, undetermined, sequela
T470X5AAdverse effect of histamine H2-receptor blockers, initial encounter
T470X5SAdverse effect of histamine H2-receptor blockers, sequela
T471X1APoisoning by other antacids and anti-gastric-secretion drugs, accidental (unintentional), initial encounter
T471X1SPoisoning by other antacids and anti-gastric-secretion drugs, accidental (unintentional), sequela
T471X2APoisoning by other antacids and anti-gastric-secretion drugs, intentional self-harm, initial encounter
T471X2SPoisoning by other antacids and anti-gastric-secretion drugs, intentional self-harm, sequela
T471X3APoisoning by other antacids and anti-gastric-secretion drugs, assault, initial encounter
T471X3SPoisoning by other antacids and anti-gastric-secretion drugs, assault, sequela
T471X4APoisoning by other antacids and anti-gastric-secretion drugs, undetermined, initial encounter
T471X4SPoisoning by other antacids and anti-gastric-secretion drugs, undetermined, sequela
T471X5AAdverse effect of other antacids and anti-gastric-secretion drugs, initial encounter
T471X5SAdverse effect of other antacids and anti-gastric-secretion drugs, sequela
T472X1APoisoning by stimulant laxatives, accidental (unintentional), initial encounter
T472X1SPoisoning by stimulant laxatives, accidental (unintentional), sequela
T472X2APoisoning by stimulant laxatives, intentional self-harm, initial encounter
T472X2SPoisoning by stimulant laxatives, intentional self-harm, sequela
T472X3APoisoning by stimulant laxatives, assault, initial encounter
T472X3SPoisoning by stimulant laxatives, assault, sequela
T472X4APoisoning by stimulant laxatives, undetermined, initial encounter
T472X4SPoisoning by stimulant laxatives, undetermined, sequela
T472X5AAdverse effect of stimulant laxatives, initial encounter
T472X5SAdverse effect of stimulant laxatives, sequela
T473X1APoisoning by saline and osmotic laxatives, accidental (unintentional), initial encounter
T473X1SPoisoning by saline and osmotic laxatives, accidental (unintentional), sequela
T473X2APoisoning by saline and osmotic laxatives, intentional self-harm, initial encounter
T473X2SPoisoning by saline and osmotic laxatives, intentional self-harm, sequela
T473X3APoisoning by saline and osmotic laxatives, assault, initial encounter
T473X3SPoisoning by saline and osmotic laxatives, assault, sequela
T473X4APoisoning by saline and osmotic laxatives, undetermined, initial encounter
T473X4SPoisoning by saline and osmotic laxatives, undetermined, sequela
T473X5AAdverse effect of saline and osmotic laxatives, initial encounter
T473X5SAdverse effect of saline and osmotic laxatives, sequela
T474X1APoisoning by other laxatives, accidental (unintentional), initial encounter
T474X1SPoisoning by other laxatives, accidental (unintentional), sequela
T474X2APoisoning by other laxatives, intentional self-harm, initial encounter
T474X2SPoisoning by other laxatives, intentional self-harm, sequela
T474X3APoisoning by other laxatives, assault, initial encounter
T474X3SPoisoning by other laxatives, assault, sequela
T474X4APoisoning by other laxatives, undetermined, initial encounter
T474X4SPoisoning by other laxatives, undetermined, sequela
T474X5AAdverse effect of other laxatives, initial encounter
T474X5SAdverse effect of other laxatives, sequela
T475X1APoisoning by digestants, accidental (unintentional), initial encounter
T475X1SPoisoning by digestants, accidental (unintentional), sequela
T475X2APoisoning by digestants, intentional self-harm, initial encounter
T475X2SPoisoning by digestants, intentional self-harm, sequela
T475X3APoisoning by digestants, assault, initial encounter
T475X3SPoisoning by digestants, assault, sequela
T475X4APoisoning by digestants, undetermined, initial encounter
T475X4SPoisoning by digestants, undetermined, sequela
T475X5AAdverse effect of digestants, initial encounter
T475X5SAdverse effect of digestants, sequela
T476X1APoisoning by antidiarrheal drugs, accidental (unintentional), initial encounter
T476X1SPoisoning by antidiarrheal drugs, accidental (unintentional), sequela
T476X2APoisoning by antidiarrheal drugs, intentional self-harm, initial encounter
T476X2SPoisoning by antidiarrheal drugs, intentional self-harm, sequela
T476X3APoisoning by antidiarrheal drugs, assault, initial encounter
T476X3SPoisoning by antidiarrheal drugs, assault, sequela
T476X4APoisoning by antidiarrheal drugs, undetermined, initial encounter
T476X4SPoisoning by antidiarrheal drugs, undetermined, sequela
T476X5AAdverse effect of antidiarrheal drugs, initial encounter
T476X5SAdverse effect of antidiarrheal drugs, sequela
T477X1APoisoning by emetics, accidental (unintentional), initial encounter
T477X1SPoisoning by emetics, accidental (unintentional), sequela
T477X2APoisoning by emetics, intentional self-harm, initial encounter
T477X2SPoisoning by emetics, intentional self-harm, sequela
T477X3APoisoning by emetics, assault, initial encounter
T477X3SPoisoning by emetics, assault, sequela
T477X4APoisoning by emetics, undetermined, initial encounter
T477X4SPoisoning by emetics, undetermined, sequela
T477X5AAdverse effect of emetics, initial encounter
T477X5SAdverse effect of emetics, sequela
T478X1APoisoning by other agents primarily affecting gastrointestinal system, accidental (unintentional), initial encounter
T478X1SPoisoning by other agents primarily affecting gastrointestinal system, accidental (unintentional), sequela
T478X2APoisoning by other agents primarily affecting gastrointestinal system, intentional self-harm, initial encounter
T478X2SPoisoning by other agents primarily affecting gastrointestinal system, intentional self-harm, sequela
T478X3APoisoning by other agents primarily affecting gastrointestinal system, assault, initial encounter
T478X3SPoisoning by other agents primarily affecting gastrointestinal system, assault, sequela
T478X4APoisoning by other agents primarily affecting gastrointestinal system, undetermined, initial encounter
T478X4SPoisoning by other agents primarily affecting gastrointestinal system, undetermined, sequela
T478X5AAdverse effect of other agents primarily affecting gastrointestinal system, initial encounter
T478X5SAdverse effect of other agents primarily affecting gastrointestinal system, sequela
T4791XAPoisoning by unspecified agents primarily affecting the gastrointestinal system, accidental (unintentional), initial encounter
T4791XSPoisoning by unspecified agents primarily affecting the gastrointestinal system, accidental (unintentional), sequela
T4792XAPoisoning by unspecified agents primarily affecting the gastrointestinal system, intentional self-harm, initial encounter
T4792XSPoisoning by unspecified agents primarily affecting the gastrointestinal system, intentional self-harm, sequela
T4793XAPoisoning by unspecified agents primarily affecting the gastrointestinal system, assault, initial encounter
T4793XSPoisoning by unspecified agents primarily affecting the gastrointestinal system, assault, sequela
T4794XAPoisoning by unspecified agents primarily affecting the gastrointestinal system, undetermined, initial encounter
T4794XSPoisoning by unspecified agents primarily affecting the gastrointestinal system, undetermined, sequela
T4795XAAdverse effect of unspecified agents primarily affecting the gastrointestinal system, initial encounter
T4795XSAdverse effect of unspecified agents primarily affecting the gastrointestinal system, sequela
T480X1APoisoning by oxytocic drugs, accidental (unintentional), initial encounter
T480X1SPoisoning by oxytocic drugs, accidental (unintentional), sequela
T480X2APoisoning by oxytocic drugs, intentional self-harm, initial encounter
T480X2SPoisoning by oxytocic drugs, intentional self-harm, sequela
T480X3APoisoning by oxytocic drugs, assault, initial encounter
T480X3SPoisoning by oxytocic drugs, assault, sequela
T480X4APoisoning by oxytocic drugs, undetermined, initial encounter
T480X4SPoisoning by oxytocic drugs, undetermined, sequela
T480X5AAdverse effect of oxytocic drugs, initial encounter
T480X5SAdverse effect of oxytocic drugs, sequela
T481X1APoisoning by skeletal muscle relaxants [neuromuscular blocking agents], accidental (unintentional), initial encounter
T481X1SPoisoning by skeletal muscle relaxants [neuromuscular blocking agents], accidental (unintentional), sequela
T481X2APoisoning by skeletal muscle relaxants [neuromuscular blocking agents], intentional self-harm, initial encounter
T481X2SPoisoning by skeletal muscle relaxants [neuromuscular blocking agents], intentional self-harm, sequela
T481X3APoisoning by skeletal muscle relaxants [neuromuscular blocking agents], assault, initial encounter
T481X3SPoisoning by skeletal muscle relaxants [neuromuscular blocking agents], assault, sequela
T481X4APoisoning by skeletal muscle relaxants [neuromuscular blocking agents], undetermined, initial encounter
T481X4SPoisoning by skeletal muscle relaxants [neuromuscular blocking agents], undetermined, sequela
T481X5AAdverse effect of skeletal muscle relaxants [neuromuscular blocking agents], initial encounter
T481X5SAdverse effect of skeletal muscle relaxants [neuromuscular blocking agents], sequela
T48201APoisoning by unspecified drugs acting on muscles, accidental (unintentional), initial encounter
T48201SPoisoning by unspecified drugs acting on muscles, accidental (unintentional), sequela
T48202APoisoning by unspecified drugs acting on muscles, intentional self-harm, initial encounter
T48202SPoisoning by unspecified drugs acting on muscles, intentional self-harm, sequela
T48203APoisoning by unspecified drugs acting on muscles, assault, initial encounter
T48203SPoisoning by unspecified drugs acting on muscles, assault, sequela
T48204APoisoning by unspecified drugs acting on muscles, undetermined, initial encounter
T48204SPoisoning by unspecified drugs acting on muscles, undetermined, sequela
T48205AAdverse effect of unspecified drugs acting on muscles, initial encounter
T48205SAdverse effect of unspecified drugs acting on muscles, sequela
T48291APoisoning by other drugs acting on muscles, accidental (unintentional), initial encounter
T48291SPoisoning by other drugs acting on muscles, accidental (unintentional), sequela
T48292APoisoning by other drugs acting on muscles, intentional self-harm, initial encounter
T48292SPoisoning by other drugs acting on muscles, intentional self-harm, sequela
T48293APoisoning by other drugs acting on muscles, assault, initial encounter
T48293SPoisoning by other drugs acting on muscles, assault, sequela
T48294APoisoning by other drugs acting on muscles, undetermined, initial encounter
T48294SPoisoning by other drugs acting on muscles, undetermined, sequela
T48295AAdverse effect of other drugs acting on muscles, initial encounter
T48295SAdverse effect of other drugs acting on muscles, sequela
T483X1APoisoning by antitussives, accidental (unintentional), initial encounter
T483X1SPoisoning by antitussives, accidental (unintentional), sequela
T483X2APoisoning by antitussives, intentional self-harm, initial encounter
T483X2SPoisoning by antitussives, intentional self-harm, sequela
T483X3APoisoning by antitussives, assault, initial encounter
T483X3SPoisoning by antitussives, assault, sequela
T483X4APoisoning by antitussives, undetermined, initial encounter
T483X4SPoisoning by antitussives, undetermined, sequela
T483X5AAdverse effect of antitussives, initial encounter
T483X5SAdverse effect of antitussives, sequela
T484X1APoisoning by expectorants, accidental (unintentional), initial encounter
T484X1SPoisoning by expectorants, accidental (unintentional), sequela
T484X2APoisoning by expectorants, intentional self-harm, initial encounter
T484X2SPoisoning by expectorants, intentional self-harm, sequela
T484X3APoisoning by expectorants, assault, initial encounter
T484X3SPoisoning by expectorants, assault, sequela
T484X4APoisoning by expectorants, undetermined, initial encounter
T484X4SPoisoning by expectorants, undetermined, sequela
T484X5AAdverse effect of expectorants, initial encounter
T484X5SAdverse effect of expectorants, sequela
T485X1APoisoning by other anti-common-cold drugs, accidental (unintentional), initial encounter
T485X1SPoisoning by other anti-common-cold drugs, accidental (unintentional), sequela
T485X2APoisoning by other anti-common-cold drugs, intentional self-harm, initial encounter
T485X2SPoisoning by other anti-common-cold drugs, intentional self-harm, sequela
T485X3APoisoning by other anti-common-cold drugs, assault, initial encounter
T485X3SPoisoning by other anti-common-cold drugs, assault, sequela
T485X4APoisoning by other anti-common-cold drugs, undetermined, initial encounter
T485X4SPoisoning by other anti-common-cold drugs, undetermined, sequela
T485X5AAdverse effect of other anti-common-cold drugs, initial encounter
T485X5SAdverse effect of other anti-common-cold drugs, sequela
T486X1APoisoning by antiasthmatics, accidental (unintentional), initial encounter
T486X1SPoisoning by antiasthmatics, accidental (unintentional), sequela
T486X2APoisoning by antiasthmatics, intentional self-harm, initial encounter
T486X2SPoisoning by antiasthmatics, intentional self-harm, sequela
T486X3APoisoning by antiasthmatics, assault, initial encounter
T486X3SPoisoning by antiasthmatics, assault, sequela
T486X4APoisoning by antiasthmatics, undetermined, initial encounter
T486X4SPoisoning by antiasthmatics, undetermined, sequela
T486X5AAdverse effect of antiasthmatics, initial encounter
T486X5SAdverse effect of antiasthmatics, sequela
T48901APoisoning by unspecified agents primarily acting on the respiratory system, accidental (unintentional), initial encounter
T48901SPoisoning by unspecified agents primarily acting on the respiratory system, accidental (unintentional), sequela
T48902APoisoning by unspecified agents primarily acting on the respiratory system, intentional self-harm, initial encounter
T48902SPoisoning by unspecified agents primarily acting on the respiratory system, intentional self-harm, sequela
T48903APoisoning by unspecified agents primarily acting on the respiratory system, assault, initial encounter
T48903SPoisoning by unspecified agents primarily acting on the respiratory system, assault, sequela
T48904APoisoning by unspecified agents primarily acting on the respiratory system, undetermined, initial encounter
T48904SPoisoning by unspecified agents primarily acting on the respiratory system, undetermined, sequela
T48905AAdverse effect of unspecified agents primarily acting on the respiratory system, initial encounter
T48905SAdverse effect of unspecified agents primarily acting on the respiratory system, sequela
T48991APoisoning by other agents primarily acting on the respiratory system, accidental (unintentional), initial encounter
T48991SPoisoning by other agents primarily acting on the respiratory system, accidental (unintentional), sequela
T48992APoisoning by other agents primarily acting on the respiratory system, intentional self-harm, initial encounter
T48992SPoisoning by other agents primarily acting on the respiratory system, intentional self-harm, sequela
T48993APoisoning by other agents primarily acting on the respiratory system, assault, initial encounter
T48993SPoisoning by other agents primarily acting on the respiratory system, assault, sequela
T48994APoisoning by other agents primarily acting on the respiratory system, undetermined, initial encounter
T48994SPoisoning by other agents primarily acting on the respiratory system, undetermined, sequela
T48995AAdverse effect of other agents primarily acting on the respiratory system, initial encounter
T48995SAdverse effect of other agents primarily acting on the respiratory system, sequela
T490X1APoisoning by local antifungal, anti-infective and anti-inflammatory drugs, accidental (unintentional), initial encounter
T490X1SPoisoning by local antifungal, anti-infective and anti-inflammatory drugs, accidental (unintentional), sequela
T490X2APoisoning by local antifungal, anti-infective and anti-inflammatory drugs, intentional self-harm, initial encounter
T490X2SPoisoning by local antifungal, anti-infective and anti-inflammatory drugs, intentional self-harm, sequela
T490X3APoisoning by local antifungal, anti-infective and anti-inflammatory drugs, assault, initial encounter
T490X3SPoisoning by local antifungal, anti-infective and anti-inflammatory drugs, assault, sequela
T490X4APoisoning by local antifungal, anti-infective and anti-inflammatory drugs, undetermined, initial encounter
T490X4SPoisoning by local antifungal, anti-infective and anti-inflammatory drugs, undetermined, sequela
T490X5AAdverse effect of local antifungal, anti-infective and anti-inflammatory drugs, initial encounter
T490X5SAdverse effect of local antifungal, anti-infective and anti-inflammatory drugs, sequela
T491X1APoisoning by antipruritics, accidental (unintentional), initial encounter
T491X1SPoisoning by antipruritics, accidental (unintentional), sequela
T491X2APoisoning by antipruritics, intentional self-harm, initial encounter
T491X2SPoisoning by antipruritics, intentional self-harm, sequela
T491X3APoisoning by antipruritics, assault, initial encounter
T491X3SPoisoning by antipruritics, assault, sequela
T491X4APoisoning by antipruritics, undetermined, initial encounter
T491X4SPoisoning by antipruritics, undetermined, sequela
T491X5AAdverse effect of antipruritics, initial encounter
T491X5SAdverse effect of antipruritics, sequela
T492X1APoisoning by local astringents and local detergents, accidental (unintentional), initial encounter
T492X1SPoisoning by local astringents and local detergents, accidental (unintentional), sequela
T492X2APoisoning by local astringents and local detergents, intentional self-harm, initial encounter
T492X2SPoisoning by local astringents and local detergents, intentional self-harm, sequela
T492X3APoisoning by local astringents and local detergents, assault, initial encounter
T492X3SPoisoning by local astringents and local detergents, assault, sequela
T492X4APoisoning by local astringents and local detergents, undetermined, initial encounter
T492X4SPoisoning by local astringents and local detergents, undetermined, sequela
T492X5AAdverse effect of local astringents and local detergents, initial encounter
T492X5SAdverse effect of local astringents and local detergents, sequela
T493X1APoisoning by emollients, demulcents and protectants, accidental (unintentional), initial encounter
T493X1SPoisoning by emollients, demulcents and protectants, accidental (unintentional), sequela
T493X2APoisoning by emollients, demulcents and protectants, intentional self-harm, initial encounter
T493X2SPoisoning by emollients, demulcents and protectants, intentional self-harm, sequela
T493X3APoisoning by emollients, demulcents and protectants, assault, initial encounter
T493X3SPoisoning by emollients, demulcents and protectants, assault, sequela



Centers for Medicare & Medicaid Services, 7500 Security Boulevard Baltimore, MD 21244
08 Mar 2024 10:29:37
CMS, code-revision=359, description-revision=1383